neurocirugia
neurocirugia. abril 30-07
para estudiantes fernando y catalina VIII sem unilibre
Outcome of Thrombolytic Treatment for
Stroke Poor When Iron Stores High
Medscape Jan 10 -07
patients with increased serum ferritin concentrations before thrombolytic treatment are more likely to have a poor clinical outcome, according to researchers in
"Iron overload has been associated with greater oxidative stress and brain injury in experimental cerebral ischemia and reperfusion," Dr. Monica Millan, of Universitat Autonoma de Barcelona, and colleagues write in the January issue of Stroke.
To see if iron levels affect stroke outcome, the researchers studied 134 consecutive patients with acute ischemic stroke treated with tissue plasminogen activator (t-PA) at four centers. They determined serum ferritin levels, as an index of cellular iron stores, at baseline and at 24 and 72 hours after treatment.
Overall, 73 patients (54.5%) had poor outcome at 90 days. Ferritin concentrations at baseline were significantly higher in patients with poor outcome compared to those with good outcome, at a median of 165.1 ng/mL versus 17.5 ng/mL, respectively (p < 0.001).
"Serum ferritin levels higher than 79 ng/mL before tissue plasminogen activator treatment were independently associated with poor outcome (OR, 117)," Dr. Millan's team reports. "The model provided good sensitivity (95.1%) and specificity (89.0%)."
If these findings are confirmed, "iron chelators or free radical trapping agents should be used to reduce the neurotoxic effects of iron in patients with acute ischemic stroke who are treated with intravenous t-PA," the team concludes.
Stroke 2007;38:90-95.
Hemicrania Continua-like Headache Associated With Internal Carotid Artery Dissection May Respond to Indomethacin medscape abr 27-07
Avi Ashkenazi MD; Muhammad A. Abbas MD; Dinesh K. Sharma MD; Stephen D. Silberstein MD; FACP
Headache. 2007;47(1):127-130. ©2007 Blackwell Publishing
Posted 04/13/2007
Abstract and Introduction
Abstract
Hemicrania continua (HC) is an idiopathic, chronic disorder characterized by a continuous, strictly unilateral headache associated with ipsilateral cranial autonomic symptoms. The symptoms of HC typically respond dramatically to indomethacin therapy. We describe a patient with traumatic internal carotid artery dissection, who presented with a clinical picture mimicking HC that initially responded to indomethacin. Patients with a clinical picture similar to HC should be managed with a high index of suspicion for a possible cervical arterial dissection.
Introduction
Hemicrania continua (HC) is a chronic, indomethacin-responsive headache disorder characterized by a continuous, strictly unilateral head pain that fluctuates in intensity and is associated with ipsilateral cranial autonomic symptoms.[1,2] HC was first described by Medina and Diamond in 1981 as a "cluster headache variant" responding to indomethacin.[3] Sjaastad and Spierings described 2 more cases and coined the term HC.[4] Initially considered a rare disorder, HC has been increasingly recognized over the past 2 decades.[5] The International Headache Society (IHS) has recently published specific diagnostic criteria for HC.[6] The rapid and dramatic response to indomethacin is a hallmark of HC, and indeed is one of the IHS diagnostic criteria for this disorder.[2,6] However, the mechanism of the beneficial effect of indomethacin on HC, which far exceeds the effect of other NSAIDs on this disorder, remains unknown. Moreover, the specificity of indomethacin responsiveness for this disorder has been debated.[7] The etiology and pathogenesis of HC are currently unknown.
We describe a patient with traumatic internal carotid artery (ICA) dissection, who presented with a clinical picture that mimicked HC, with a transient response to indomethacin.
Case Report
The patient is a 51-year-old, right-handed woman who presented to our clinic in December 2004 with a chief complaint of severe, continuous, right-sided headache. In May 2003, while riding a bus that was involved in a motor vehicle accident, the patient had right-sided neck and shoulder trauma. She remained fully conscious and had no symptoms immediately after the trauma. The headache appeared 3 weeks later. One month after the onset of headache she noticed drooping of her right eyelid. She was admitted to a local hospital, where a magnetic resonance angiography (MRA) of the neck revealed a dissection of the right ICA (Fig. 1). A brain MRI was normal. She was started on anticoagulant therapy, which was stopped after a year. Her headache was continuous from the onset until she was seen at our clinic. At presentation, she complained of a continuous, strictly right-sided headache that was moderate to severe in intensity, with superimposed paroxysms of short-lasting (duration of up to 30 seconds), shooting pain in the same area. She reported on occasional right-sided tearing and rhinorrhea, as well as nausea. She was severely disabled by her headache, unable to work or attend family or social activities. Her sleep was disrupted by the pain and she was taking morphine tablets daily.
Figure 1.
Neck MRA showing a dissection of the right internal carotid artery.
Her past medical history included arterial hypertension and depression. Prior to her neck trauma, she only had occasional episodes of tension type headache.
On examination, she was in obvious distress from pain. Her mood was depressed. Miosis and eyelid ptosis were present on the right. A repeat MRA of the neck showed no healing of the right
Figure 2.
The dissection failed to heal 13 months later.
The patient was started on oral indomethacin 75 mg/day, and was instructed to stop all other pain medications. Twenty-four hours after the initiation of indomethacin treatment, she experienced significant headache relief. The indomethacin dose was increased gradually to 225 mg/day and pantoprazole 40 mg/day was added for gastrointestinal protection. At that point, she became headache-free and had no adverse effects from her medications.
Six months later, her headache recurred and gradually increased in severity, despite continued indomethacin use. Verapamil, at a dose of 240 mg/day, was added to her treatment regimen, with a very good response. At the most recent follow-up in January 2006, the patient was doing well, with only mild headaches.
Comments
This patient presented with the clinical picture that resembled HC, i.e., a strictly unilateral, continuous headache of moderate to severe intensity for >3 months, associated with ipsilateral cranial autonomic symptoms.[6] Her headache also responded initially to indomenthacin. However, that response was transient.
Few patients who presented with a clinical phenotype resembling HC associated with a specific disease have been described in the literature.[8] The etiologies of these "secondary HC" cases include head trauma, a sphenoid bone tumor, lung cancer, and sphenoid sinusitis.[9-12] Lay and Newman described 4 patients (3 of whom were women) who presented with a clinical picture of HC that started in temporal relation to head trauma.[9] All 4 patients had headache resolution or significant headache improvement with indomethacin treatment, while other analgesics, including NSAIDs other than indomethacin, were ineffective. Antonaci and Sjaastad reported on a 28-year-old woman with HC secondary to a mesenchymal tumor in the sphenoid bone.[10] Her headache abated with indomethacin treatment, but the effect of indomethacin faded after 2 months of treatment. Successful treatment of the tumor resulted in elimination of the headache. In another case report, a 61-year-old man presented with continuous hemicranial pain associated with lung cancer.[11] There were no associated cranial autonomic symptoms. The patient's headache was entirely responsive to indomethacin. Another report was of a 53-year-old woman who presented with continuous unilateral headache associated with autonomic symptoms.[12] Indomethacin provided significant headache relief. On evaluation, sphenoid and posterior ethmoid sinusitis was found ipsilateral to her head pain. Treatment of the sinusitis with antibiotic enabled the indomethacin therapy to be discontinued.
Our case, along with the above recently reported one, shows that an ICA dissection may present with HC-like headache that may respond initially to indomethacin. It has been suggested that patients with HC who require a high dose of indomethacin, or who experience fading of the indomethacin effect, may have an underlying pathology.[16] Our case, where the response to indomethacin faded 6 months after initiation of treatment, supports this theory. The persistence of the carotid dissection in our patient probably played a role in the persistence of her headache. She had multiple neck MRAs after the neck trauma, and all showed no healing of the dissection. Carotid dissections usually heal within several months, and by that time the symptoms associated with the dissection abate, as described by Rogalewski et al.[14]
The occurrence of headache in association with carotid dissection is consistent with the observation that stimulation of the carotid artery results in pain referred ipsilaterally to the head.[15] The cranial autonomic symptoms seen in ICA dissection may result from damage to the sympathetic fibers that travel along the carotid artery wall.
Patients who present with a clinical picture resembling HC should be managed with a high index of suspicion for a possible cervical arterial dissection, even when the headache responds initially to indomethacin.
CLICK HERE for subscription information about this journal.
References
--------------------------------- end |